Stay updated on Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial page.

Latest updates to the Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded a consolidated Locations section listing participating sites by state (Arizona, Arkansas, California, Colorado, Florida, Louisiana, North Carolina, Oklahoma, Rhode Island, Tennessee, Texas) and removed the previous per-state location subsections. This update improves visibility of where the study is conducted.SummaryDifference1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedRevision: v3.3.2 is now shown, replacing the prior v3.2.0. Other visible content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check48 days agoChange DetectedThe funding/status notice at the bottom of the page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check62 days agoChange DetectedResults have been posted on 2025-07-14 and study record dates (First Submitted, Last Update, Primary Completion, Study Completion) have been updated. This update clarifies the current status and available outcome information for the trial.SummaryDifference0.4%

- Check91 days agoChange DetectedSummary of changes: updated operating-status notice and a version bump to v3.2.0, replacing the previous v3.1.0.SummaryDifference2%

- Check98 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial page.